Financial reports
10-Q
2021 Q3
Quarterly report
3 Nov 21
10-Q
2021 Q2
Quarterly report
4 Aug 21
10-Q
2021 Q1
Quarterly report
30 Apr 21
10-K
2020 FY
Annual report
24 Feb 21
10-Q
2020 Q3
Quarterly report
6 Nov 20
10-Q
2020 Q2
Quarterly report
31 Jul 20
10-Q
2020 Q1
Quarterly report
8 May 20
10-K
2019 FY
Annual report
28 Feb 20
10-Q
2019 Q3
Quarterly report
31 Oct 19
10-Q
2019 Q2
Quarterly report
31 Jul 19
Current reports
8-K
Completion of Acquisition or Disposition of Assets
17 Feb 22
8-K
Clayton, Dubilier & Rice funds to invest in new enterprise; former Aetna Chairman and CEO Ron Williams to be Chairman of combined company
5 Jan 22
8-K
Castlight Health Announces Third Quarter 2021 Results
2 Nov 21
8-K
Castlight Health Announces Second Quarter 2021 Results
3 Aug 21
8-K
Submission of Matters to a Vote of Security Holders
10 Jun 21
8-K
Castlight Health Announces First Quarter 2021 Results
29 Apr 21
8-K
Castlight Health Announces Fourth Quarter and Full Year 2020 Results
23 Feb 21
8-K
Amendments to Articles of Incorporation or Bylaws
21 Dec 20
8-K
Castlight Health Announces Third Quarter 2020 Results
5 Nov 20
8-K
Regulation FD Disclosure
4 Aug 20
Registration and prospectus
15-12B
Securities registration termination
28 Feb 22
25-NSE
Exchange delisting
17 Feb 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Feb 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Feb 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Feb 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Feb 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Feb 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Feb 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Feb 22
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Feb 22
Proxies
DEFA14A
Additional proxy soliciting materials
20 Apr 21
DEF 14A
Definitive proxy
20 Apr 21
DEFA14A
Additional proxy soliciting materials
21 May 20
DEFA14A
Additional proxy soliciting materials
24 Apr 20
DEF 14A
Definitive proxy
24 Apr 20
PRE 14A
Preliminary proxy
14 Apr 20
DEFA14A
Additional proxy soliciting materials
26 Apr 19
DEF 14A
Definitive proxy
26 Apr 19
DEF 14A
Definitive proxy
27 Apr 18
DEFA14A
Additional proxy soliciting materials
27 Apr 18
Other
SEC STAFF
SEC staff action: Order
18 Feb 20
SEC STAFF
SEC staff action: Order
6 Feb 20
EFFECT
Notice of effectiveness
14 Feb 17
UPLOAD
Letter from SEC
13 Feb 17
CORRESP
Correspondence with SEC
10 Feb 17
CORRESP
Correspondence with SEC
28 Jan 16
UPLOAD
Letter from SEC
21 Jan 16
CT ORDER
Confidential treatment order
14 Mar 14
EFFECT
Notice of effectiveness
13 Mar 14
CORRESP
Correspondence with SEC
11 Mar 14